Article Details

Soleno Therapeutics (NASDAQ:SLNO) Upgraded by Zacks Investment Research to Hold

Retrieved on: 2021-01-15 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Soleno Therapeutics (NASDAQ:SLNO) Upgraded by Zacks Investment Research to Hold. View article details on hiswai:

Excerpt

Finally, Schonfeld Strategic Advisors LLC acquired a new stake in shares of Soleno Therapeutics in the third quarter worth $98,000. 54.45% of the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up